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Background: Foot-and-mouth disease virus (FMDV) initiates infection via recognition of one of at least four
cell-surface integrin molecules αvβ1, αvβ3, αvβ6, or αvβ8 by a highly conserved Arg-Gly-Asp (RGD) amino acid
sequence motif located in the G-H loop of VP1. Within the animal host, the αvβ6 interaction is believed to be the
most relevant. Sub-neutralizing levels of soluble secreted αvβ6 (ssαvβ6) was used as a selective pressure during
passages in vitro to explore the plasticity of that interaction.
Results: Genetically stable soluble integrin resistant (SIR) FMDV mutants derived from A24 Cruzeiro were selected
after just 3 passages in cell culture in the presence of sub-neutralizing levels of ssαvβ6. SIR mutants were
characterized by: replication on selective cell lines, plaque morphology, relative sensitivity to ssαvβ6 neutralization,
relative ability to utilize αvβ6 for infection, as well as sequence and structural changes. All SIR mutants maintained
an affinity for αvβ6. Some developed the ability to attach to cells expressing heparan sulfate (HS) proteoglycan,
while others appear to have developed affinity for a still unknown third receptor. Two classes of SIR mutants were
selected that were highly or moderately resistant to neutralization by ssαvβ6. Highly resistant mutants displayed a
G145D substitution (RGD to RDD), while moderately resistant viruses exhibited a L150P/R substitution at the
conserved RGD + 4 position. VP1 G-H loop homology models for the A-type SIR mutants illustrated potential
structural changes within the integrin-binding motif by these 2 groups of mutations. Treatment of O1 Campos with
ssαvβ6 resulted in 3 SIR mutants with a positively charged VP3 mutation allowing for HS binding.
Conclusions: These findings illustrate how FMDV particles rapidly gain resistance to soluble receptor prophylactic
measures in vitro. Two different serotypes developed distinct capsid mutations to circumvent the presence of
sub-neutralizing levels of the soluble cognate receptor, all of which resulted in a modified receptor tropism that
expanded the cell types susceptible to FMDV. The identification of some of these adaptive mutations in known
FMDV isolates suggests these findings have implications beyond the cell culture system explored in these studies.
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Foot-and-mouth disease virus (FMDV) is responsible for
the most economically important viral disease of cattle and
other cloven-hoofed animals [1-5]. FMDV, the prototypic
member of the Aphthovirus genus of Picornaviridae, utilizes
in vitro four integrin heterodimers (αvβ1, αvβ3, αvβ6, and
αvβ8) for attachment to host cells and entry via clathrin-
coated pits (CCPs) [6-14]. A prominent surface-exposed
loop connecting the βG-βH strands (G-H loop) of the VP1* Correspondence: elizabeth.rieder@ars.usda.gov
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reproduction in any medium, provided the orcapsid protein contains a highly conserved Arg-Gly-Asp
(RGD) motif, a recognition sequence for the αv-integrin
family of cell surface receptors [6,15-17]. Limited trypsin
proteolysis removes the G-H loop, producing FMDV parti-
cles considerably less infectious relative to untreated vir-
ions, highlighting the importance of this region for
productive infection [18-20]. Following integrin binding,
CCPs internalize virus into acidic endosomes where
uncoating occurs. FMDV field isolates continually passaged
in cell culture adapt to utilize heparan sulfate (HS) as an al-
ternative receptor, and exhibit attenuated pathogenicity
[21-24].
Previously, soluble αvβ3 and αvβ6 lacking the trans-
membrane and cytoplasmic tail domains were shown toral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Receptor repertoire of tested cell lines
Cell
Line
αvβ1 αvβ3 αvβ6 αvβ8 HS Reference
LFBK + + + * + Figure 1 (this paper); [29]
CHO
K1
- - - - + [30-37]
CHO
677
- - - - - [21,30,38-41]
IBRS2 - - - + - [16,42]
COS-1 * - - - + Figures 3 and 6 (this paper);
[7,36,37]
+ Confirmed expression of the receptor molecule on the cell line indicated.
- Confirmed lack of expression of the receptor molecule on the cell line
indicated.
* Unclear if the receptor molecule is expressed on the cell line indicated.
The receptor profile of αvβ1, αvβ3, αvβ6, αvβ8, and HS on 6 cell lines used was
tabulated with references to studies that directly demonstrated the receptor
profile or did so indirectly by virus growth profiles.
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serotype A and O FMDV particles with soluble secreted
bovine αvβ3 and αvβ6 prior to application on permissive
cell lines was investigated as an antiviral therapy. Inter-
estingly, only soluble αvβ6 limited FMDV attachment to
host cells by competing for receptor binding sites on
virus particles. Soluble αvβ3 exhibited a low affinity inter-
action with the virus particles and failed to attach to
FMDV in the same manner as αvβ6 with no significant
effect on infectivity. It remains to be determined
whether binding to blocking molecules such as soluble
receptor, will impact FMDV interaction with the cell-
membrane receptor or affect viral growth.
Here, we conducted in vitro experiments to evaluate the
selective pressure exerted by soluble receptor protein on
FMDV attachment and examined the evolution of virus-
host cell interactions. Studies conducted with poliovirus
and its cognate receptor [26,27] showed that surface and
internal capsid residues regulate attachment to the recep-
tor and conformational change of the virus. Here, sub-
neutralizing levels of soluble secreted bovine αvβ6 (ssαvβ6)
were used to develop soluble receptor resistant mutants of
FMDVA24 Cruzeiro. Of the 4 αv-integrins used by FMDV
for host cell attachment, the β6 heterodimer was selected
on the basis that ssαvβ6 most substantially impeded FMDV
infection [25]. Additionally, the β6 heterodimer was shown
to be most responsible for the tissue tropism of FMDV in
cattle [28]. Following 3 successive passages of FMDV
(serotype A and serotype O) pre-treated and co-incubated
with ssαvβ6 on the LFBK cell line, which is permissive to
infection by all 7 serotypes of FMDV (Figure 1, Table 1)
[29], virus was isolated that persisted despite the presence
of soluble integrin (SI). The A-type isolates exhibited
mutations in the normally conserved RGD motif or just
outside of it within the G-H loop of VP1, while the O-type
mutants displayed changes in VP3 and residues proximal
to the VP1 RGD motif. SI resistant (SIR) FMDV mutants
were further characterized for altered receptor tropism,
relative sensitivity to neutralization by SI, as well as se-
quence and structural alterations in the G-H loop.Figure 1 Integrin expression profile. BHK-21, CHO 677, and LFBK cell lys
(ITGβ3), anti-β6 integrin (ITGβ6), and anti-RHA. Equivalent loading between
ladder bands are indicated.Results
Selection of FMDV serotype A SIR mutants
To examine the adaptability of serotype A FMDV (repre-
sented by A24 Cruzeiro) to the presence of soluble recep-
tor during infection, we employed ssαvβ6, which is
preferentially exploited by serotype A FMDV for host cell
attachment [7,25]. As previously described, ectodomains
of αv and β6 integrin subunits were secreted from stably
transfected cells, which were properly folded and capable
of heterodimerization (data not shown) [25]. The bovine
kidney LFBK cell line was selected for these studies on the
basis that it is susceptible to infection by all 7 FMDV sero-
types, similar to primary bovine kidney cell culture and
[29]. Western blot analysis confirmed that LFBK cells ex-
press both β3 and β6 integrins (Figure 1, Table 1). As
expected, CHO 677 cells [30,38] did not express β3 and β6
integrins [21,30-33,39-41]. While BHK-21 cells expressed
β3 integrin, we were unable to detect the presence of β6
integrin. As an additional control, RNA Helicase A
(RHA), known to be expressed in all 3 cell lines, was also
detected. By extension, these findings allowed for the po-
tential that both αvβ3 and αvβ6 could be found on the sur-
face of LFBK cells, which is consistent with repeatedates were examined by Western blot probing with: anti-β3 integrin
lanes was confirmed by probing with anti-tubulin-α. Molecular weight
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non-HS-adapted field isolates of FMDV (data not shown).
Wild-type (WT) FMDV A24 Cruzeiro was pre-
incubated with 10 μg/mL ssαvβ6 (sub-neutralizing con-
centration for A24 Cruzeiro, Additional file 1: Figure S1)
at 37°C for 1 hour prior to application of the coated
virus on LFBK cells. As depicted in Figure 2A, LFBK
cells were infected with ssαvβ6 coated WT FMDV A24
Cruzeiro at a MOI of 1 at 37°C for 24 hours (P1).
Thirty-five plaques were isolated and used for a second
round (P2) of infection with ssαvβ6. Only 17 of the 35
infections demonstrated cytopathic effects (CPE) at 24
hpi. Isolates from 17 P2 infections were individually used
for a third selection (P3) with ssαvβ6. This resulted inFigure 2 A-SIR mutant generation. A. Schematic of A-SIR mutant produc
A- SIRs relative to A24 Cruzeiro after pre-treatment and co-incubation with
SIR #42 was the only virus that amplified on CHO 677 cells (right box). Tite
increasing concentrations of ssαvβ6 on LFBK monolayers for 24 h, and theonly 4 productive infections derived from A24 Cruzeiro
numbered: 15, 23, 42, and 45. The 4 soluble integrin re-
sistant (SIR) serotype A (A-type) isolates (designated A-
SIR #15, A-SIR #23, A-SIR #42, and A-SIR #45) were
subject to a final selection with ssαvβ6, where by 24 hpi
A-type SIR isolates 15, 23, and 45 produced 100% CPE
and isolate 42 produced 50% CPE.
After multiple passages in cell culture, FMDV has been
shown to gain the ability to attach to host cells via HS
[14,21-24,43]. To determine if the A-type SIR mutants
adapted to use HS for entry, replication of these viruses on
LFBK and Chinese hamster ovary (CHO) K1 cells was com-
pared. In contrast to LFBK cells, CHO K1 cells express HS,
but not αvβ1, αvβ3 and αvβ6 (Table 1) [24,30-35]. Of note,tion. B. Comparison of the plaque morphology and titers achieved of
ssαvβ6 on LFBK (top panel) and CHO K1 (bottom panel) cells for 24 h.
rs represent PFU/mL. C. WT and A-SIR viruses were co-incubated with
calculated titers were subsequently plotted.
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αvβ5), but neither function as FMDV receptors [7,10,30].
WT and A-SIR viruses successfully infected LFBK cells
(Figure 2B, top panel). However, WT and A-SIRs #15 and
#23 were unable to infect CHO K1 cells. In contrast, A-
SIRs #42 and #45 productively infected CHO K1 cells
(Figure 2B, bottom panel). Thus, we suggest that A-SIRs
#42 and #45 circumvented ssαvβ6 neutralization by expand-
ing their receptor preference to include HS, as previously
observed under other conditions with different FMDV sero-
types [23,24].
The A-type SIR mutants diverged with respect to their
plaque morphologies on different cell lines. WT and A-SIR
mutants maintained relatively large plaque sizes on LFBK
cells (Figure 2B, top panel). On CHO K1 monolayers, A-
SIRs #42 and #45 showed reduced plaque size relative to
LFBK cells (Figure 2B, lower panel). Comparative viral
growth on LFBK and CHO K1 cells suggests some A-SIRs
might utilize HS. To examine this further, the growth
analysis was expanded to include the CHO 677 cell line
(Figure 1, Table 1) [39,40,44]. In addition, the IBRS2 cell
line with a unique receptor profile where FMDV infection
is initiated via αvβ8 [9,16,42], was also examined (Table 1).
IBRS2 cells were permissive to infection by WT and A-SIR
viruses, growing to titers comparable to LFBK cells
(Table 2). Interestingly, A-SIR #42 productively infected
CHO 677 cells (Figure 2B, Table 2). SIR #42 grew to
roughly equivalent titers on CHO 677 and CHO K1 cells
(Figure 2B, Table 2). Viral growth on CHO 677 cells sug-
gested this A-SIR mutant adapted to utilize an as yet un-
identified and uncharacterized third FMDV receptor
[21,41]. It was inferred that growth of A-SIR #45 on CHO
K1 cells but not CHO 677 cells was indicative that this
virus exploited HS. Different growth patterns for each A-
SIR mutant on different cell lines also suggested these
viruses are genetically distinct. These findings illustrated
the rapid adaptability (after only 3 passages) of serotype A
FMDV to overcome interference with host cell attachment.
A-SIR mutants exhibit reduced sensitivity to SI
neutralization
Next, the relative sensitivities of A-SIR mutants to ssαvβ6
neutralization were examined relative to their WTTable 2 Growth comparison of A24 Cruzeiro WT and A-type S
Virus LFBK CHO K1 CHO 677
A24-WT 7 x 108 - -
A-SIR #15 1.1 x 107 - -
A-SIR #23 8.3 x 106 - -
A-SIR #42 7.4 x 107 2.4 x 104 2.6 x 104
A-SIR #45 1.3 x 107 2.7 x 103 -
Numerical values represent virus titers in plaque forming units per milliliter (PFU/m
Dashes indicate no plaque detected at the lowest dilution of virus tested (1/10).counterpart. Each virus was pre-incubated with ssαvβ6 at
gradually increasing concentrations (5, 10, 20, 30, and
40 μg/mL), applied to LFBK monolayers, and evaluated
for reductions in virus titer. As shown in Figure 2C, the
four A-SIR mutants could be divided into 2 classes with
respect to sensitivity to neutralization by ssαvβ6: a highly
resistant (#15 and #23, Class I) and a moderately resist-
ant class (#42 and #45, Class II). A-SIRs #15 and #23
grew to titers 200–1000 fold higher than WT with in-
creasing ssαvβ6, while mutants #42 and #45 exhibited
titers 20–100 fold higher than WT (Figure 2C). Cumula-
tively, these findings reinforced the supposition that pre-
and co-incubation of ssαvβ6 acts as a selective pressure
forcing FMDV particles to quickly select for resistance
to the treatment.
A-SIR mutants continue to utilize αvβ6
Since the A-SIR mutants exhibited reduced sensitivity to
ssαvβ6 neutralization, we investigated whether they ex-
hibit an altered integrin preference: shifting from αvβ6 to
another integrin or a non-integrin receptor. The capabil-
ity of A-SIRs to infect cells expressing distinct integrins
was tested using a previously established transient
transfection-infection assay [45]. COS-1 cells do not
support FMDV infection and lack integrins used by
FMDV (Table 1) [7]. These cells were co-transfected
with plasmids encoding the full-length αv-integrin sub-
unit and 1 of 4 different full-length β subunits (β1, β3,
β5, or β6). Expression was confirmed by immunocyto-
chemical staining (Figure 3A). Of note, the antibody
used to detect the αvβ1 only recognizes the β1 subunit;
as such, positive staining may be reflective of other β1
containing integrin heterodimers.
WT virus and A-SIR mutants were incubated on
the cells transiently expressing integrin with 35S-methio-
nine. After 24 hours, levels of viral protein synthesis
were evaluated by radioimmunoprecipitation (RIP)
(Figure 3B). Based on the sets where FMDV proteins
(3D, VP0, VP1-3) were detected, it could be inferred as
to which integrin heterodimers was/were used by WT
and A-SIR viruses to gain entry to COS-1 cells for repli-
cation. Consistent with previous reports, viral protein
synthesis was detected for A24 Cruzeiro WT in cellsIRs on 6 cell lines
CHO 677 αvβ6 IBRS2 COS-1
6.3 x 107 6 x 108 -
2.8 x 106 4 x 107 -
1.8 x 106 2 x 107 -
5.6 x 106 6.5 x 107 -
2 x 107 1 x 107 -
L).
Figure 3 A-SIR mutants maintain αvβ6 affinity. A. Expression of αv and β subunits (β1, β3, β5, or β6) examined by immuno-histochemical
staining using indicated antibodies. Untransfected cells probed as a negative control. B. RIP analysis of transfected cells infected with: A24
Cruzeiro and A-SIRs in the presence of 35S-methionine. NT, not transfected. PC, positive control: virus-infected LFBK cells.
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#15 and #23 were only amplified on αvβ6 expressing
cells. A-SIRs #42 and #45 infected cells displaying αvβ1
and αvβ6. However, the signal for virus proteins was no-
ticeably lower for A-SIR #42 and #45 relative to WT,
though we cannot exclude the possibility that this was
partially due to differences in transfection efficiencies.
Besides WT, A-SIR #45 was the only other virus able to
infect via αvβ3. Interestingly, although resistant to
neutralization by ssαvβ6, all 4 A-SIR viruses replicated
on αvβ6 expressing COS-1 cells. Thus, it was inferred
that all 4 A-SIR mutants maintained sufficient affinity
for αvβ6 to continue to infect cells via this receptor.
To reinforce the supposition that the A-SIR viruses
retained the ability to bind αvβ6, CHO 677 cells, which
could not permit FMDV infection except for A-SIR #42,
were transiently transfected with αvβ6 as was done for
COS-1 cells (data not shown). The expression of αvβ6
restored infectivity of WT and A-SIR viruses, with titers
within 0.5 to 1 log less than on LFBK cells (Table 2),
with A-SIR #45 attaining a titer 1 log higher than both
class I SIRs. Notably, A-SIR #42 achieved titers 2 logs
higher than on untransfected CHO 677 cells, suggesting
αvβ6 is the preferred surface receptor for this virus.
Amino acid substitutions detected in A-SIR mutants
To further distinguish A-SIR viruses from their parental
counterpart, A-SIR mutants were examined for altera-
tions in their nucleotide and amino acid sequences rela-
tive to WT (Accession #AY593768). No amino acid
substitutions were detected in VP4, VP2, or VP3, with a
single silent mutation detected in VP3. Interestingly, the2 A-type SIR classes exhibited 2 corresponding types of
mutations in VP1 summarized in Table 3 and Figure 4.
Class I A-SIRs that were highly resistant to ssαvβ6 (#15
and #23) displayed a G145D amino acid substitution in
the RGD motif considered essential for integrin inter-
action. The V154A substitution distinguished A-SIR #23
from #15. Class II A-type SIRs moderately resistant to
ssαvβ6 (#42 and #45) exhibited substitutions at the RGD
+ 4 position with L150P for #42 and L150R for #45.
Moreover, A-SIR #42 displayed 2 additional amino acid
alterations upstream of the RGD motif: E95K and S96L.
Previous reports have described the helical segment im-
mediately C-terminal to the RGD motif as contributing
to the interaction between FMDV and its cognate integ-
rin receptor, specifically, amino acid positions RGD + 1
and RGD + 4. The RGD + 1 and RGD + 4 side chains
face out like those of the RGD motif and are frequently
occupied by leucine residues [8,14,46-49]. While proline
substitution at the RGD + 4 position was previously
detected in the A5 Westerwald FRG/58 field isolate ([50]
b; [51]) and serially passaged populations of a serotype C
FMDV strain [21], the arginine substitution at this pos-
ition appears unprecedented. Cumulatively, the P1
sequences support the findings that 2 distinct classes of
SIR mutants were derived from A24 Cruzeiro: where
each class exhibited distinct forms of amino acid substi-
tutions localized to the VP1 G-H loop.
Structural predictions of A-SIR mutant modifications
After defining the amino acid changes within VP1 in the
A-SIR mutants (Figure 4), we explored how those
changes might affect the overall structure of the
Table 3 Sequence comparison of the P1 region of A24 Cruzeiro and A-SIRs
Gene A24 Cruzeiro WT A-SIR #15 and #23 (Class I) A-SIR #42 and #45 (Class II)
Nucleotidea Codonb Amino acidc Nucleotidea Codonb Amino acidc Nucleotidea Codonb Amino acidc
VP2 C50 cgG —— —— —— —— G5045 cgA Silent
VP1 G6 acG —— C6 acC Silent C6 acC Silent
VP1 G283 Gaa E95 —— —— —— A28342 Aaa K95
VP1 C287 tCa S96 —— —— —— T28742 tTa L96
VP1 G434 gGc G145 A434 gAc D145 —— —— ——
VP1 T449 cTc L150 —— —— —— C44942 cCc42 P15042
G44945 cGc45 R15045
VP1 T461 gTc V154 C46123 gCc A15423 —— —— ——
a Nucleotide differences between viruses followed by number indicating its position within the gene coding sequence.
b Lowercase letters indicate bases shared by the 2 viruses and capital letters indicate bases differing between the viruses.
c One-letter code of the encoded amino acid residues followed by number indicating residue position in the polypeptide.
P1 region of A24 Cruzeiro (Accession # AY596768) was compared against: Class I (#15 and #23) and Class II (#42 and #45) A-SIRs. Nucleotide changes relative to
WT were indicated and codon positions. Silent mutations and amino acid substitutions are indicated. A-SIR mutant numerical designations were superscripted.
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structure has been solved for FMDV O1/BFS 1860/UK/
67 (Accession 1FOD) [52]. Using the coordinates of
1FOD as a template, homology structures were gener-
ated of WT A24 Cruzeiro VP1 as well as those of the 4
A-SIR mutants using the Geno3D algorithm [53]. For
each virus, 10 different “best fit” homology models were
generated for VP1. Representative images of the G-H
loop region were given particular scrutiny (Figure 5).
The RGD to RDD substitution detected in class I A-
SIR mutants #15 and #23 placed a bulky negatively
charged residue into the center of the integrin binding
site, which can be seen projecting outward in the hom-
ology structures generated. The introduction of D145
“spread out” the adjacent side chains within the RGD
motif, increasing the distance between the R144 and
D146 side chains relative to WT (Figure 5). In all 10 of
the predicted tertiary structures, the amino acid alter-
ation failed to effect any significant change in the back-
bone structure of this region of VP1.
The previously undetected L150R substitution at the
RGD + 4 position of class II A-SIR #45 replaces a linear
non-polar amino acid side chain with a positivelyFigure 4 Amino acid substitutions within the P1 region of A-SIR muta
substitutions identified in the P1 region of A-SIR mutants after viral RNA fro
substitutions in P1.charged residue. Interestingly, Geno3D failed to predict
a consensus structure for the A-SIR #45 G-H loop. Class
II A-SIR mutant #42 exhibited a L150P substitution at
RGD + 4, which was previously identified in FMDV A5
Westerwald FRG/58 [50,51]. The homology model of
the A-SIR #42 G-H loop revealed the proline residue
introducing a kink that “compressed” the RGD motif
with the three side chains in much closer proximity than
WT (Figure 5). This structural prediction was essentially
the opposite of what was produced for the class I A-SIR
mutants.
In addition to L150P, A-SIR #42 also displayed 2 sub-
stitutions upstream of the RGD: E95K and S96L, which
are proximal to the VP1-VP3 interface. Using Geno3D,
ribbon diagrams were generated of capsid protomers
from WT and A-SIRs to determine if the protein inter-
face was disrupted (Additional file 2: Figure S2). A short
helical domain observed at the VP1-VP3 interface in the
WT sequence was notably absent with the E95K/S96L
substitution, replaced with a loop structure. With L150P
previously detected in A5 Westerwald, E95K/S96L may
be more significant to the adaptation of A_SIR #42. We
concluded that the mutations elucidated in the A-SIRnts. Schematic of the FMDV genome summarizing the amino acid
m A24 Cruzeiro and A-SIRs was sequenced for amino acid
Figure 5 Structural prediction of the effect of the A-SIR amino acid substitutions on the G-H loop. Depicted are 2 angles (A and B) of
models of the VP1 G-H loop of A24 Cruzeiro and representative class I and class II A-SIRs. RGD motif is indicated, and residues are colored:
arginine (R), blue; glycine (G), green; aspartic acid (D), red. RGD + 4 position (L/P + 4) is violet. Black arrows indicate altered directionality of the
amino acid side chains in A-SIR RGD/RDD sites.
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likely to affect cellular recognition.
O1 Campos derived SIR mutants circumvent ssαvβ6 by a
different mechanism
A-SIR mutants derived from A24 Cruzeiro overcame the
selective pressure introduced by ssαvβ6 by compensatory
mutations targeted to the RGD motif or the RGD + 4
position within the VP1 G-H loop. In an effort to deter-
mine if a similar strategy would be exploited by a differ-
ent FMDV serotype, the experiment was repeated
whereby O1 Campos was pre-treated and passaged three
times in the continued presence of 10 μg/mL ssαvβ6
(also a sub-neutralizing concentration for O1 Campos,
data not shown). Three O-type SIR viruses were recov-
ered designated O-SIR #1, O-SIR #9, and O-SIR #46
(Figure 6A). All three O-SIRs produced similar small
plaque forming units on LFBK cells relative to their WT
progenitor (Figure 6B, top panel). Unlike the WT virus,
the O-SIRs productively infected CHO K1 cells
(Figure 6B, bottom panel), achieving titers approximately
1 log lower than on LFBK cells (Table 4). This suggested
that the O-SIRs adapted to the presence of ssαvβ6 by
selecting an affinity for HS, which represents a well-
characterized strategy employed by serotype O FMDV
[22,23,54]. Each O-SIR mutant produced distinct plaque
morphologies on CHO K1 cells; with large plaques for
O-SIR #1, medium-sized plaques for O-SIR #9, and
small pinprick plaques for O-SIR #46 (Figure 6B, bottom
panel). Interestingly, like the A-type SIR mutant #42, O-
SIR #9 could replicate, albeit to a limited titer, on CHO677 cells (Figure 6B, right panel and Table 4). When
CHO 677 cells transiently expressing αvβ6 were substi-
tuted in this assay, infectivity was restored for all O-SIR
mutants and O1 Campos WT, with titers equivalent to
or exceeding those on LFBK cells (Table 4). This particu-
lar finding was consistent with what was observed for
the A-SIR viruses, where affinity for αvβ6 was main-
tained. Additionally, both O1 Campos and the O-SIR
mutants demonstrated titers 1–2 logs higher on IBRS2
cells relative to LFBK cells (Table 4), which suggested
that these viruses infect via αvβ8 with greater efficiency.
Further analysis revealed that all three O-SIRs were
uniformly 2 logs more resistant to neutralization by
ssαvβ6 up to 20 μg of ssαvβ6 (Figure 6C). However, while
this resistance was maintained by O-SIR #1 and O-SIR
#9 above 20 μg ssαvβ6, O-SIR #46 was inhibited by
ssαvβ6 at concentrations above 20 μg. Initial examina-
tions of the reliance of the O-SIRs on different integrin
heterodimers revealed the presence of FMDV proteins
in untransfected COS-1 cells infected with the O-SIR
mutants, similar to the pattern observed for O-SIR
infected LFBK cells (Figure 6D). No increase in viral pro-
tein synthesis was observed for cells transiently expressing
integrins (data not shown). Like CHO K1 cells, COS-1
cells express HS, thus it was inferred that the O-SIR
mutants had circumvented ssαvβ6 neutralization by adapt-
ing to utilize HS for host cell attachment.
Given the disparities in plaque morphology and sensi-
tivity to soluble integrin neutralization, it was expected
that the O-type SIR mutants would be genetically dis-
tinct. In contrast to A-SIRs, compensatory mutations
Figure 6 O1 Campos derived SIR mutants exhibit distinctive alterations. A. Schematic of O1 Campos derived O-SIR mutant production.
B. Comparison of the growth characteristics of O-SIRs relative to O1 Campos after ssαvβ6 co-incubation on LFBK and CHO K1 cells. O-SIR #9 was
the only virus that amplified on CHO 677 cells. Titers represent PFU/mL. C. WT and O-SIR viruses were co-incubated with ssαvβ6 on LFBK
monolayers for 24 h, and the calculated titers were subsequently plotted. D. RIP analysis of untransfected LFBK and COS-1 cells infected with: O1
Campos and O-SIRs in the presence of 35S-methionine. NT, not transfected (COS-1). PC, positive control (LFBK). E. FMDV genome depicting amino
acid substitutions identified in the P1 region of O-SIR mutants.
Table 4 Growth comparison of O1 Campos WT and O-type SIRs on 6 cell lines
Virus LFBK CHO K1 CHO 677 CHO 677- αvβ6 IBRS2 COS-1
O1C-WT 1.5 x 106 - - 4 x 108 8 x 107 -
O-SIR #1 1.1 x 106 1.5 x 105 - 9 x 105 1.9 x 108 *
O-SIR #9 3.8 x 105 4 x 104 8.0 x 102 1.5 x 106 5 x 108 *
O-SIR #46 2.6 x 105 2 x 104 - 1.5 x 106 1.6 x 108 *
Numerical values represent virus titers in plaque forming units per milliliter (PFU/mL).
Dashes indicate no plaque detected at the lowest dilution of virus tested (1/10).
Asterisks indicate limited abortive infection without plaque formation, indicated by thinning of the cell monolayer.
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within VP3 (Figure 6E). The mutations detected in the
O-SIRs were consistent with those previously found in
HS-adapted serotype O FMDV passaged multiple times
in cell culture with a signature H56R substitution in
VP3 [22,23,54]. An additional D60A substitution in VP3
and an E113V substitution in the VP1 G-H loop were
found in all O-SIR viruses. O-SIRs were distinguished
from each other by 2 unique amino acid substitutions:
R155W in the VP1 G-H loop of O-SIR #1 and Q28L in
VP1 and V90A in VP2 of O-SIR #9. Notably, the con-
served RGD motif and RGD + 4 amino acid positions
were unchanged.
Cumulatively, the development and characterization of
the A-SIR and O-SIR FMDV mutants and the evolution
of the virus-host interaction under the selective pressure
of soluble integrin treatment was determined in the
present study.Discussion
Distinct lineages of RNA viruses are frequently referred
to as “quasi-species” due to their inherent mutability
[47,55]. Their rapid adaptability stems from the lack of
“proofreading” function in the RNA-dependent RNA
polymerases responsible for amplification of RNA viral
genomes. The poliovirus RNA polymerase delivers ap-
proximately 1 error in 2200 bases, which is significant
for a virus genome of approximately 7500 nucleotides
[56]. Constant variation with each duplicated RNA viral
population represents a stumbling block in the develop-
ment of anti-viral therapies. A previous study explored
using soluble receptor treatments to impair FMDV in-
fection [25,49]. Here, we investigated the effect of sub-
neutralizing levels of soluble secreted αvβ6 (ssαvβ6) on
FMDV replication in cells and documented the rapid
emergence of resistant FMDV populations, how they cir-
cumvented the selective pressure of ssαvβ6, and the
strategies deployed as they adapted.
Previous studies have investigated the effect of mul-
tiple passaging in cell culture on FMDV acquisition of
alternative receptors, attenuated phenotypes, and for the
dispensability of the RGD motif [21,49,57]. For instance,
following 100 passages of a serotype C FMDV (C-S8c1)
in cell culture, the virus was able to enter cells by an
integrin-independent manner and multiple mutations
were identified in the variant genomes [21]. For serotype
A12 virus, it has been shown that mutations obtained
during adaptation of field (bovine) isolates to cell culture
localize downstream of the RGD and those mutations
appear to alter the affinity for the integrin receptor [49].
Here, four SI resistant (SIR) FMD viruses derived from
A24 Cruzeiro and three derived from O1 Campos were
rapidly selected after only 3 rounds of cell cultureselection in the continued presence of ssαvβ6. The A-SIR
mutants could be separated into 2 classes that were ei-
ther highly or moderately resistant to neutralization by
ssαvβ6. Highly resistant A-SIRs (Class I) did not select
HS as a secondary receptor and maintained αvβ6 affinity.
These variants displayed a G145D substitution in the
highly conserved VP1 RGD motif. The moderately re-
sistant A-SIRs (Class II) also retained αvβ6 affinity and
appeared to either utilize HS or an as yet unidentified
and uncharacterized third FMDV receptor. Moreover,
similar to A24 Cruzeiro, all 4 A-SIR mutants were amp-
lified on IBRS2 cells, indicating that the A-SIRs have
maintained the ability to infect and replicate on cells
expressing an abundance of αvβ8, which can also func-
tion as a FMDV receptor [9,16,42].
Class I A-SIR Mutants
A-SIR mutants appear to have circumvented ssαvβ6 treat-
ment by 2 different routes. Substitution of an aspartic acid
(G145D) in the RGD motif (Figure 4) rendered A-SIR #15
and 23 (Class I) highly resistant to ssαvβ6 (Figure 2C)
while paradoxically maintaining use of αvβ6 for infection
(Figure 3B). Notably, class I A-SIRs did not adapt to utilize
HS. Interestingly, this RDD mutation in the cell receptor
binding site has been detected in a field strain of Asia1
virus (Asia1/JS/CHA/05) after just 2 passages, one in vivo
and one in vitro [57]. RDD Asia1 variants showed no
change in their ability to replicate in established cell lines,
nor did it alter clinical onset of disease in animals tested
[57]. While the environmental pressure that selected for
RDD Asia1 variants is unknown, it suggests that this mu-
tation might be a natural adaptation mechanism that
could manifest across different FMDV serotypes. This hy-
pothesis is supported by the observation that natural out-
breaks of serotype A FMDV featuring the RDD amino
acid substitution have occurred in Argentina on two occa-
sions: A25-Arg/59 (GenBank #AY593769) and A25-Arg/
61 (GenBank #AY593789).
The likely reason for the selection of a modified RGD
was also investigated using homology models of the VP1
G-H loop structure and position of the RDD side chains
(Figure 5). The data showed an additional negative
charge provided by G145D widened the gap between the
side chains of R144 and D146. Potentially, the widening
of the RDD side chains or the introduction of an add-
itional negatively charged side chain might diminish the
affinity of the motif for the integrin by sterically compli-
cating the binding of ssαvβ6, which is not anchored to a
membrane, to the virus particle during pre-treatment in
solution. Correspondingly, by reducing the affinity but
not ablating the interaction with αvβ6 (Figure 3B,
Table 2), unoccupied RDD sites on the virus particle
after pre-treatment and subsequent co-incubation with
ssαvβ6 likely allow infection of host cells via αvβ6.
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In contrast, moderately resistant Class II A-SIRs left the
RGD intact, but substituted a key amino acid at the
RGD + 4 position [8,14,46-48], with the conserved leu-
cine replaced with proline for A-SIR #42 and arginine
for A-SIR #45. L150P was previously identified in FMDV
A5 Westerwald FRG/58 [50,51] as well as a multiply
passaged serotype C FMDV [21,58]. However, L150R
appears unprecedented. Interestingly, while both viruses
replicated in CHO K1 cells, only A-SIR #42 infected
CHO 677 cells. However, both class II A-SIRs exhibited
preference for αvβ6 over alternative surface molecules
(Figure 2, Table 2). Given L150P was previously detected
in the WT field strain A5 Westerwald [51], it will be
interesting to explore in the future whether this amino
acid alteration was solely responsible for shifting recep-
tor tropism to allow infection of cells devoid of FMDV
integrin receptors and HS [21,30,38,41]. However, two
additional mutations detected in VP1, E95K and S96L,
might also contribute or be exclusively responsible for
the A-SIR #42 phenotype.
Homology modeling was also employed to illustrate how
Class II amino acid substitutions affected both the G-H
loop (Figure 5) and the capsid protomer (Additional file 2:
Figure S2). In contrast to Class I A-SIRs, L150P appears to
compress the side chains projecting from the RGD motif,
where R144 and D146 are in closer proximity than in A24
Cruzeiro or Class I A-SIRs (Figure 5). The unique E95K/
S96L substitutions localized to the VP1-VP3 interface, po-
tentially altering capsid protomer stability (Additional file 2:
Figure S2). Modeling algorithms failed to generate a con-
sensus structure for the G-H loop of A-SIR #45, where
multiple potential side chain angles for L150R altered the
shape and presentation of the RGD motif (data not shown).
O-SIR mutants
When the approach used to generate the A-SIRs was ap-
plied to O1 Campos, this resulted in three distinctive O-
SIR mutants that bind to HS and that carried a signature
H56R mutation. This particular mutation has been
observed in attenuated HS-adapted FMDVs [22,23,54].
Similar to their A-type counterparts, the O-SIRs also
could be amplified on IBRS2 cells suggesting that the se-
lective pressure of co-incubation with ssαvβ6 did not ab-
rogate the affinity for αvβ8. However, unlike A24
Cruzeiro and the A-SIRs, O1 Campos and the O-type
SIR mutants amplified 2–3 logs more in IBRS2 cells
relative to LFBK cells, thus it could be inferred that sero-
type O FMDV may have a preference for αvβ8 as a re-
ceptor. As such it would be intriguing to explore the
effects of successive passages of O1 Campos in the pres-
ence of ssαvβ8 in the future. Lastly, it is interesting to
note that the mutations accumulated by the O-SIRs were
not in the VP1 RGD motif, but rather peripheral to itand at locations in VP3, separate from the primary site
of attachment to the host cell.
Conclusions
Together the results of this study have shed light on the
plasticity of FMDV serotype A and O interactions with
its primary cognate receptor: αvβ6. Amino acid substitu-
tions detected in SIR mutants were rapidly selected to
overcome soluble receptor neutralization. Thus, the tol-
erance of the VP1 G-H loop to amino acid substitutions
plays an essential role in cell receptor adaptability of
FMDV. Interestingly, mutations identified in the current
study have been also identified in FMDV field isolates
causing outbreaks suggesting that similar selective pres-
sures may exist in the natural host environment. The
mode and relative speed with which FMDV was able to
adapt to a selective pressure, represented here by ssαvβ6,
highlights both the evolutionary advantage of highly
mutable RNA viruses and the challenges of designing ef-
fective antiviral therapies against these pathogens.
Materials and methods
Materials
Fugene-6 was purchased from Roche (Nutley, NJ). Mouse
monoclonal anti-β3 integrin (ITGβ3) was purchased from
Abcam (Cambridge, MA). Rabbit polyclonal anti-β6 integ-
rin (ITGβ6) was purchased from Sigma (St. Louis, MO).
Mouse monoclonal anti-β1 integrin (6S6), anti-αvβ3 integ-
rin (LM609), anti-αvβ5 integrin (15 F11), and anti-β6 in-
tegrin (CSβ6) was purchased from Millipore (Billerica,
MA). Rabbit polyclonal anti-RHA was purchased from
Bethyl Laboratories (Montgomery, TX).
Cells, viruses, and plasmids
IBRS2, COS-1, and 293a cell lines purchased from Ameri-
can Tissue Collection Company (ATCC; Manassas, VA)
were cultured in Dulbecco’s minimal eagle medium
(DMEM) with 10% fetal bovine serum (FBS) at 37°C with
5% CO2. LFBK cell line was previously described [29], and
cultured in DMEM with 10% FBS at 37°C with 5% CO2.
CHO K1 and 677 cell lines were acquired from Dr. Jeffrey
Esko [39] and cultured in Ham’s MEM (Gibco) with 10%
FBS at 37°C with 5% CO2. FMDV A24 Cruzeiro field
strain was derived from pA24-Cru [59]. FMDV O1 Cam-
pos field strain was previously described [24].
SI production
Expression and purification of ssαvβ3 and ssαvβ6 was previ-
ously described [25]. Plasmids encoding ectodomains of in-
tegrin subunits (αv, β3, and β6) were transfected using
Fugene-6 (Roche) per manufacturer’s instructions. Stable
expression was selected by incubating with G418 (αv gene
sub-cloned into pcDNA3.1-G418) and zeomycin (β3 and
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were collected and concentrated 10-fold using Centricon
Plus-70 filter devices (Millipore, Billerica, MA). Subsequent
protein concentration measured between 125–250 μg/mL.Radio-immunoprecipitation (RIP)
Virus-infected cells grown overnight in the presence of
35S-methionine were lysed with 1% Triton X100. Ali-
quots of each sample were precipitated with 20%
trichloroacetic acid (TCA) to determine the counts per
minute (cpm). Lysates were mixed with Protein A/G
agarose beads, tumbled 15 minutes, centrifuged at
1500 rpm 10 minutes, and the supernatants collected.
Recovered supernatant was tumbled with indicated anti-
bodies (6S6, LM609, 15 F11, and CSβ6) 1 hour at 4°C.
The mixture was tumbled overnight at 4°C with fresh
Protein A/G agarose. Afterwards, the agarose was
washed 3 times with NET/NP40 buffer (NaCl, EDTA,
Tris, Nonidet-P40). Finally, the agarose was boiled in
sample buffer without β-mercaptoethanol, pelleted, the
supernatants separated by SDS-PAGE, and the gel exam-
ined by autoradiography.Transient transfection-infection assay
Assay was conducted as previously described [45]. Two
sets of COS-1 or CHO 677 cells were transfected with 2
plasmids: one encoding full-length αv-integrin subunit
and the other encoding 1 of 4 different full-length β sub-
units (β1, β3, β5, or β6). The first sets were examined by
immuno-histochemical staining to confirm expression,
using antibodies: 6S6 (αvβ1), LM609 (αvβ3), 15 F11
(αvβ5), and CSβ6 (αvβ6). 6S6 binds the β1 subunit and
COS-1 cells express α5β1, which is not a cellular recep-
tor for FMDV [11,12,21]. The other sets were infected
with WT and SIR viruses at a MOI of 1 in 35S-methionine
containing media. Subsequently, virus-infected cell lysates
were examined by RIP for virus-specific bands: 3D, VP0,
and VP1-3.Virus titer assay
One hour post-adsorption, the inoculum was removed,
and cells washed in a mild acid solution followed by
virus growth media (VGM, DMEM containing L-glu-
tamine). VGM was then added and cells incubated
24 hours at 37°C. Afterwards, virus-infected cells were
harvested and titers determined by plaque assay as pre-
viously described [60]. Plates were fixed, stained with
crystal violet (0.3% in Histochoice; Amresco, Solon,
OH), and plaques counted. Values calculated for number
of plaque-forming units (PFUs) per milliliter (mL) were
plotted using Microsoft Excel (Microsoft Corporation,
Redmond, WA). Assays were performed in triplicate.Western blot
Protein samples were separated by Nu-PAGEW pre-cast
gel system (Invitrogen), and electro-blotted onto nitro-
cellulose (Sigma). After blocking with 5% milk, proteins
were detected with indicated primary integrin antibodies
(anti-β3, Abcam and anti-β6, Sigma) followed by HRP-
conjugated goat-anti-mouse or goat-anti-rabbit anti-
bodies (Bethyl Laboratories), respectively. Cellular tubu-
lin, employed as a loading control, was detected with
HRP-conjugated anti-tubulin-α (Abcam, Cambridge,
MA). HRP was reacted with WestDura SuperSignal
chemiluminescent reagent (Pierce) and visualized on X-
ray film (X-Omat; Kodak, N.Y., USA).
Sequencing of the FMDV P1 Region
The P1 region in twenty FMDV isolates were sequenced
from PCR product with sequencing primers providing at
least 3X coverage across 3,000 base pairs. PCR products
were purified with QIAQuick spin columns (Qiagen) in
accordance with the manufacturer's instructions. Se-
quencing reaction mixtures (10 μl) contained 2.5 μM
primer, 20 ng of PCR product, and 0.75 μl of Big Dye
(Applied Biosystems) in molecular biology-grade water.
The sequence cycling conditions were 30 s of pre-
incubation at 85°C; 25 cycles of 10 s at 96°C, 5 s at 50°C,
and 4 min at 60°C; and a 10-min 60°C final extension.
The sequencing reaction mixtures were purified with
Agencourt’s CleanSEQ system in accordance with the
manufacturer's instructions (Beckman Coulter).
Structural analysis
Amino acid sequences of SIRs were used to construct hom-
ology models of the G-H loop and capsid protomers using
the Geno3D algorithm [53]. Ten most likely structures
were generated using a solved structure as a template. Two
X-ray crystal structures for the major immunogenic site of
FMDV designated 1FOD [52] and 1ZBE [61] in the Protein
Data Bank (PDB) were selected as templates. Hypothetical
structures were examined using DeepView [62,63], and a
consensus structure for each sequence was selected.
Additional files
Additional file 1: Figure S1. Soluble integrin neutralization assay.
Titration experiment performed where A24 Cruzeiro was pre-incubated
with gradually increasing amounts of ssαvβ6 to determine a suitable sub-
neutralizing soluble receptor concentration.
Additional file 2: Figure S2. Structural prediction of the effect of the
A-SIR amino acid substitutions on the capsid protomer. Depicted are 3
ribbon models of the FMDV capsid protomer (excluding VP4) of A24
Cruzeiro (A) and class I (B) and class II (C) A-SIRs. Black arrows indicate the
RGD motif and the RGD + 4 position. Blue arrows indicate the VP1-VP3
interface. VP1 is yellow, VP2 is blue, and VP3 is red.
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